Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Hicks

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 22, 2008
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistryHadi Yaziji, Clive R Taylor, Neal S Goldstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patientsDavid G Hicks, Brian J Yoder, Sarah Short, et al.
Breast Cancer Research and Treatment|September 30, 2008
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapyYi Zhang, Anieta M Sieuwerts, Michelle McGreevy, et al.
Virchows Archiv : an International Journal of Pathology|October 19, 2023
Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancerCharo Garrido, Melissa Manoogian, Dhiraj Ghambire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Reply to E.A. Rakha et alAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast CancerHyun-Seok Kim, Christopher B Umbricht, Peter B Illei, et al.
Archives of Pathology & Laboratory Medicine|July 23, 2019
Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision MedicineCarolyn C Compton, James A Robb, Matthew W Anderson, et al.
Archives of Pathology & Laboratory Medicine|June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerM Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 22, 2008
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistryHadi Yaziji, Clive R Taylor, Neal S Goldstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patientsDavid G Hicks, Brian J Yoder, Sarah Short, et al.
Breast Cancer Research and Treatment|September 30, 2008
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapyYi Zhang, Anieta M Sieuwerts, Michelle McGreevy, et al.
Virchows Archiv : an International Journal of Pathology|October 19, 2023
Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancerCharo Garrido, Melissa Manoogian, Dhiraj Ghambire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Reply to E.A. Rakha et alAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateAntonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast CancerHyun-Seok Kim, Christopher B Umbricht, Peter B Illei, et al.
Archives of Pathology & Laboratory Medicine|July 23, 2019
Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision MedicineCarolyn C Compton, James A Robb, Matthew W Anderson, et al.
Archives of Pathology & Laboratory Medicine|June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerM Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Pageof 14